BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22922821)

  • 1. Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.
    Wadsworth LP; Lorius N; Donovan NJ; Locascio JJ; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    Dement Geriatr Cogn Disord; 2012; 34(2):96-111. PubMed ID: 22922821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease.
    Apostolova LG; Di LJ; Duffy EL; Brook J; Elashoff D; Tseng CH; Fairbanks L; Cummings JL
    Dement Geriatr Cogn Disord; 2014; 37(5-6):315-26. PubMed ID: 24481207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
    Burke SL; Maramaldi P; Cadet T; Kukull W
    Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
    J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
    Hallikainen I; Hongisto K; Välimäki T; Hänninen T; Martikainen J; Koivisto AM
    J Alzheimers Dis; 2018; 61(4):1367-1376. PubMed ID: 29376861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment.
    Ramakers IH; Verhey FR; Scheltens P; Hampel H; Soininen H; Aalten P; Rikkert MO; Verbeek MM; Spiru L; Blennow K; Trojanowski JQ; Shaw LM; Visser PJ;
    Psychol Med; 2013 May; 43(5):911-20. PubMed ID: 22954311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinations and Delusions Signal Alzheimer's Associated Cognitive Dysfunction More Strongly Compared to Other Neuropsychiatric Symptoms.
    Fuller JT; Choudhury TK; Lowe DA; Balsis S;
    J Gerontol B Psychol Sci Soc Sci; 2020 Oct; 75(9):1894-1904. PubMed ID: 30877750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
    Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum.
    Banning LCP; Ramakers IHGB; Köhler S; Bron EE; Verhey FRJ; de Deyn PP; Claassen JAHR; Koek HL; Middelkoop HAM; van der Flier WM; van der Lugt A; Aalten P; ;
    Am J Geriatr Psychiatry; 2020 Jul; 28(7):735-744. PubMed ID: 32088096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease.
    Mak E; Chin R; Ng LT; Yeo D; Hameed S
    Int J Geriatr Psychiatry; 2015 Dec; 30(12):1207-14. PubMed ID: 25754519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile.
    Donaghy PC; Ciafone J; Durcan R; Hamilton CA; Barker S; Lloyd J; Firbank M; Allan LM; O'Brien JT; Taylor JP; Thomas AJ
    Psychol Med; 2022 Apr; 52(6):1147-1155. PubMed ID: 32840196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer's disease.
    Rafii MS; Taylor CS; Kim HT; Desikan RS; Fleisher AS; Katibian D; Brewer JB; Dale AM; Aisen PS
    Am J Alzheimers Dis Other Demen; 2014 Mar; 29(2):159-65. PubMed ID: 24164929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects.
    Richard E; Schmand B; Eikelenboom P; Yang SC; Ligthart SA; Moll van Charante EP; van Gool WA;
    Dement Geriatr Cogn Disord; 2012; 33(2-3):204-9. PubMed ID: 22722671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of behavioral changes in Alzheimer's disease.
    Mega MS; Cummings JL; Fiorello T; Gornbein J
    Neurology; 1996 Jan; 46(1):130-5. PubMed ID: 8559361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
    Nagata T; Shinagawa S; Nakajima S; Plitman E; Mihashi Y; Hayashi S; Mimura M; Nakayama K
    J Alzheimers Dis; 2016; 50(3):839-45. PubMed ID: 26836181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.
    D'Onofrio G; Panza F; Sancarlo D; Paris FF; Cascavilla L; Mangiacotti A; Lauriola M; Paroni GH; Seripa D; Greco A
    J Alzheimers Dis; 2016; 51(2):427-37. PubMed ID: 26890768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study.
    Delrieu J; Desmidt T; Camus V; Sourdet S; Boutoleau-Bretonnière C; Mullin E; Vellas B; Payoux P; Lebouvier T;
    Int J Geriatr Psychiatry; 2015 May; 30(5):470-7. PubMed ID: 24953008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Exploration of Subgroups of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Risks of Conversion to Dementia or Death.
    Qiu J; Goldstein FC; Hanfelt JJ
    Am J Geriatr Psychiatry; 2022 Aug; 30(8):925-934. PubMed ID: 35067420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis.
    Zhao QF; Tan L; Wang HF; Jiang T; Tan MS; Tan L; Xu W; Li JQ; Wang J; Lai TJ; Yu JT
    J Affect Disord; 2016 Jan; 190():264-271. PubMed ID: 26540080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.